Department of Gastroenterological Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning Province, China.
World J Gastroenterol. 2019 Mar 14;25(10):1224-1237. doi: 10.3748/wjg.v25.i10.1224.
In the present study, we investigated a suppressive role of microRNA-596 (miR-596) in gastric cancer (GC). Moreover, the downregulation of miR-596 in GC cell lines was associated with an increase of miR-596 promoter methylation. We also established that miR-596 controls the expression of peroxiredoxin 1 (PRDX1), which has never been reported before, suggesting that this interaction could play an important role in GC progression.
To study the potential role and possible regulatory mechanism of miR-596 in GC.
The expression levels of miR-596 and PRDX1 in gastric cancer tissues and cell lines were detected by quantitative real-time PCR (qRT-PCR). Western blot and luciferase reporter assay were used to detect the effect of miR-596 on PRDX1 expression. Then, the proliferation, metastasis, and invasion of GC cell lines transfected with miR-596 mimics were analyzed, respectively, by Cell Counting Kit-8 proliferation assay, wound healing assay, and transwell invasion assay. Meanwhile, the methylation status of the promoter CpG islands of miR-596 in GC cell lines was detected by methylation-specific PCR (MSP).
Expression of miR-596 was decreased and PRDX1 was upregulated in GC tissues and cell lines. Overexpression of miR-596 decreased the expression of PRDX1 and luciferase reporter assays detected the direct binding of miR-596 to the 3'-untranslated region (UTR) of PRDX1 transcripts. Furthermore, we found that overexpression of miR-596 remarkably suppressed cell proliferation, migration, and invasion in GC cells. We further analyzed miR-596 promoter methylation by MSP and qRT-PCR, and found the downregulation of miR-596 was associated with promoter methylation status in GC cell lines. Moreover, DNA demethylation and reactivation of miR-596 after treatment with 5-Aza-2'-deoxycytidine inhibited the proliferative ability of GC cells.
MiR-596 has a tumor suppressive role in GC and is downregulated partly due to promoter hypermethylation. Furthermore, PRDX1 is one of the putative target genes of miR-596.
在本研究中,我们研究了 microRNA-596(miR-596)在胃癌(GC)中的抑制作用。此外,GC 细胞系中 miR-596 的下调与 miR-596 启动子甲基化的增加有关。我们还证实,miR-596 控制过氧化物还原酶 1(PRDX1)的表达,这是以前从未报道过的,表明这种相互作用可能在 GC 进展中发挥重要作用。
研究 miR-596 在 GC 中的潜在作用和可能的调节机制。
通过实时定量 PCR(qRT-PCR)检测胃癌组织和细胞系中 miR-596 和 PRDX1 的表达水平。Western blot 和荧光素酶报告基因检测用于检测 miR-596 对 PRDX1 表达的影响。然后,通过细胞计数试剂盒-8 增殖试验、划痕愈合试验和 Transwell 侵袭试验分别分析转染 miR-596 模拟物的 GC 细胞系的增殖、转移和侵袭能力。同时,通过甲基化特异性 PCR(MSP)检测 GC 细胞系中 miR-596 启动子 CpG 岛的甲基化状态。
miR-596 在 GC 组织和细胞系中的表达降低,PRDX1 上调。miR-596 的过表达降低了 PRDX1 的表达,荧光素酶报告基因检测检测到 miR-596 与 PRDX1 转录物的 3'-非翻译区(UTR)的直接结合。此外,我们发现 miR-596 的过表达显著抑制 GC 细胞的增殖、迁移和侵袭。我们通过 MSP 和 qRT-PCR 进一步分析 miR-596 启动子甲基化,发现 GC 细胞系中 miR-596 的下调与启动子甲基化状态有关。此外,5-Aza-2'-脱氧胞苷处理后 miR-596 的去甲基化和再激活抑制了 GC 细胞的增殖能力。
miR-596 在 GC 中具有肿瘤抑制作用,部分原因是启动子过度甲基化。此外,PRDX1 是 miR-596 的一个假定靶基因。